François Malouin Selected Research

GpGp

10/2013	Effect of 3',5'-cyclic diguanylic acid in a broiler Clostridium perfringens infection model.
8/2005	3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Malouin Research Topics

Disease

18	Infections 01/2022 - 05/2004
11	Mastitis 11/2021 - 04/2003
7	Bovine Mastitis 01/2022 - 08/2004
6	Cystic Fibrosis (Mucoviscidosis) 12/2015 - 01/2006
2	Inflammation (Inflammations) 11/2021 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2019 - 04/2010
2	Staphylococcal Infections 02/2007 - 04/2005
1	Hemolysis 11/2021
1	Sudden Infant Death (SID) 09/2020
1	Persistent Infection 01/2020
1	Virus Diseases (Viral Diseases) 01/2019
1	Human Influenza (Influenza) 01/2014
1	Clostridium Infections 10/2013
1	Osteomyelitis 03/2012
1	Hemolytic-Uremic Syndrome 08/2010
1	Diarrhea 08/2010
1	Pneumonia (Pneumonitis) 04/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2009
1	Body Weight (Weight, Body) 06/2006

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 08/2004
3	VaccinesIBA 05/2019 - 08/2010
2	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2010
2	tomatidineIBA 01/2020 - 05/2011
2	AminoglycosidesIBA 01/2020 - 03/2012
2	Shiga Toxin (Shigella Toxin)IBA 01/2014 - 08/2010
2	GpGpIBA 10/2013 - 08/2005
2	Fibronectins (Fibronectin)IBA 12/2008 - 04/2003
1	DNA Restriction-Modification Enzymes (Restriction Modification Systems)IBA 01/2022
1	nasIBA 01/2022
1	PediocinsIBA 11/2021
1	NisinIBA 11/2021
1	Bacteriocins (Lantibiotics)IBA 11/2021
1	3-hydroxypropionaldehydeIBA 11/2021
1	CytokinesIBA 11/2021
1	AgarIBA 11/2021
1	Hemolysin Proteins (Hemolysins)IBA 11/2021
1	AntigensIBA 08/2021
1	SiderophoresIBA 09/2020
1	LigandsIBA 09/2020
1	catechol (pyrocatechol)IBA 09/2020
1	AlkaloidsIBA 01/2020
1	SteroidsIBA 01/2020
1	Milk Proteins (Milk Protein)IBA 06/2019
1	Caseins (Casein)FDA Link 06/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	IntegrinsIBA 01/2019
1	CoagulaseIBA 08/2017
1	pirlimycinIBA 01/2017
1	Cephapirin (Cefapirin)FDA Link 01/2017
1	ChitosanIBA 01/2017
1	ceftiofurIBA 01/2017
1	Attenuated VaccinesIBA 01/2016
1	Tobramycin (Nebcin)FDA LinkGeneric 12/2015
1	LectinsIBA 01/2015
1	Biological ProductsIBA 01/2015
1	Peptides (Polypeptides)IBA 01/2014
1	PeptidomimeticsIBA 01/2014
1	AcidsIBA 01/2014
1	Hemagglutinins (Hemagglutinin)IBA 01/2014
1	FurinIBA 01/2014
1	Amoxicillin (Wymox)FDA LinkGeneric 04/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2013
1	ExotoxinsIBA 03/2013
1	Kanamycin KinaseIBA 03/2012
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 09/2011
1	AntibodiesIBA 08/2010
1	IronIBA 08/2010
1	RiboswitchIBA 04/2010
1	GuanineIBA 04/2010
1	Ceftaroline FDA Link 04/2010
1	PhytoalexinsIBA 07/2009
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2008
1	bis(3',5')-cyclic diguanylic acidIBA 02/2007
1	Trenbolone AcetateIBA 06/2006
1	Monensin (Coban)IBA 06/2006
1	Oxytetracycline (Terramycin)FDA Link 06/2006
1	estradiol 3-benzoate (estradiol benzoate)IBA 06/2006
1	Virulence Factors (Pathogenicity Factors)IBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Pharmaceutical PreparationsIBA 08/2005
1	Indicators and Reagents (Reagents)IBA 04/2005
1	Acridine OrangeIBA 04/2005
1	Carrier Proteins (Binding Protein)IBA 04/2003

Therapy/Procedure

3	Therapeutics 01/2017 - 05/2004
1	Duration of Therapy 01/2017